| Ionizing Radiation Induces Cytokines, MMP-1, TIMP-1 and Supresses Type I Collagen mRNA Expressions in Human Gingival Fibroblasts | Güler YAVAŞ,Çağdaş YAVAŞ,S. Buket BOZKURT,Özlem ATA,Sema HAKKI | 149–156 |
| Evaluation of CYP2D6 Polymorphic Types and Their Effect on Tamoxifen Efficacy Among Turkish Tamoxifen Users with Breast Cancer | Meral GÜNALDI,Melek ERKİŞİ,Cigdem AFSAR,VEHBİ ERÇOLAK,Berna DUMAN,Semra PAYDAŞ,İsmail KARA,Berksoy ŞAHİN,Abdullah TULİ,Ata SECILMIS | 157–162 |
| The Effects of Hormonotherapy Following Concomitant Use of Trastuzumab and Radiation Therapy on Late Skin Toxicity | Yasemin B. CIHAN,Vedat ARSAV | 163–170 |
| Retrospective Investigation of 49 Cases of Locally Advanced Nasopharyngeal Cancer Patients who were Given Neoadjuvant Docetaxel/Cisplatin Chemotherapy and Concomitant Chemoradiotherapy | Kemal EKİCİ,Atınç AKSU,Öztun TEMELLİ,Beyhan CEYLANER,Naciye ÖZŞEKER,Zarni HTWAY,ALPASLAN MAYADAĞLI | 171–178 |
| Comparison of CD38, ZAP70 and hTERT Expression with Known Prognostic Markers in Patients with Chronic Lymphocytic Leukemia During Five-Year Follow- up Period | FİLİZ VURAL,EMİN KARACA,Nur SOYER,CUMHUR GÜNDÜZ,Fahri ŞAHİN,Büket KOSOVA,Güray SAYDAM,Seçkin ÇAĞIRGAN,MURAT TOMBULOĞLU,FERİŞTAH FERDA ÖZKINAY,MUHSİN ÖZGÜR ÇOĞULU | 179–184 |
| Iron Overload Pattern in Multiple Myeloma at Diagnosis its Important Clinical Associations | Eylem ELİAÇIK,Berfu KORUCU,Seda BALABAN,Ayşe IŞIK,İbrahim C. HAZNEDAROĞLU,Hakan GÖKER,Salih AKSU,Nilgün SAYINALP,Yahya BÜYÜKAŞIK | 185–189 |
| Vitamin B12 Deficiency with the Absence of Anemia in Young and Middle-Aged Population | Atilla KARA,Eylem ELİAÇIK,Yahya BÜYÜKAŞIK,Osman İ. ÖZCEBE,İbrahim HAZNEDAROĞLU,Salih AKSU,ÖZLEN BEKTAŞ,Hakan GÖKER,Nilgün SAYINALP | 190–194 |
| A View from Young Oncologists on Clinical Trials in Turkey: Obstacles and Solution Proposals | Tülay AKMAN,Özgür TANRIVERDİ,Mehmet A. OZTURK,Ibrahim PETEKKAYA,BEKİR HAKAN BAKKAL,Ozlem U. SONMEZ,Nilüfer AVCI,Seyda ZENGIN,Görkem AKSU,Gökhan ÖZYİĞİT,Hüseyin ABALI | 195–201 |
| New Hopes in Retinoblastoma Treatment | Semra A. TURHAN,Osman ÇEKİÇ | 202–207 |
| Primary Non Hodgkin's Lymphoma of Cranial Dura Mater |